KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Income from Non-Controlling Interests (2016 - 2025)

LifeMD (LFMD) has disclosed Income from Non-Controlling Interests for 10 consecutive years, with $14155.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Non-Controlling Interests fell 98.08% year-over-year to $14155.0, compared with a TTM value of $1.3 million through Dec 2025, up 69.79%, and an annual FY2025 reading of $1.3 million, up 136.85% over the prior year.
  • Income from Non-Controlling Interests was $14155.0 for Q4 2025 at LifeMD, down from $249000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $839288.0 in Q3 2023 and bottomed at -$270503.0 in Q1 2021.
  • Average Income from Non-Controlling Interests over 5 years is $245556.6, with a median of $112131.0 recorded in 2021.
  • The sharpest move saw Income from Non-Controlling Interests tumbled 190.58% in 2021, then soared 2163.93% in 2023.
  • Year by year, Income from Non-Controlling Interests stood at $104830.0 in 2021, then skyrocketed by 243.57% to $360168.0 in 2022, then surged by 43.72% to $517647.0 in 2023, then surged by 42.3% to $736604.0 in 2024, then tumbled by 98.08% to $14155.0 in 2025.
  • Business Quant data shows Income from Non-Controlling Interests for LFMD at $14155.0 in Q4 2025, $249000.0 in Q3 2025, and $505000.0 in Q2 2025.